Search Results - "Monz, Brigitta U"

Does quality of life of COPD patients as measured by the generic EuroQol five-dimension questionnaire differentiate between COPD severity stages? by Rutten-van Mölken, Maureen P M H, Oostenbrink, Jan B, Tashkin, Donald P, Burkhart, Deborah, Monz, Brigitta U

“…To assess the discriminative properties of the EuroQol five-dimension questionnaire (EQ-5D) with respect to COPD severity according to Global Initiative for…”
Get more information

Cost-effectiveness of warfarin: Trial versus “real-world” stroke prevention in atrial fibrillation by Sorensen, Sonja V., MPH, Dewilde, Sarah, MSc, Singer, Daniel E., MD, Goldhaber, Samuel Z., MD, Monz, Brigitta U., MD, Plumb, Jonathan M., MSc

“…Background and Purpose Previous cost-effectiveness analyses analyzed warfarin for stroke prevention in randomized trial settings. Given the complexities of…”
Get full text

Prescribing patterns of antidepressants in Europe: Results from the Factors Influencing Depression Endpoints Research (FINDER) study by Bauer, Michael, Monz, Brigitta U, Montejo, Angel L, Quail, Deborah, Dantchev, Nicolas, Demyttenaere, Koen, Garcia-Cebrian, Ana, Grassi, Luigi, Perahia, David G.S, Reed, Catherine, Tylee, Andre

“…Abstract Antidepressant prescribing patterns and factors influencing the choice of antidepressant for the treatment of depression were examined in the Factors…”
Get full text

Representativeness of the dabigatran, apixaban and rivaroxaban clinical trial populations to real-world atrial fibrillation patients in the United Kingdom: a cross-sectional analysis using the General Practice Research Database by Lee, Sally, Monz, Brigitta U, Clemens, Andreas, Brueckmann, Martina, Lip, Gregory Y H

“…Objective Three oral anticoagulants have reported study results for stroke prevention in patients with atrial fibrillation (AF) (dabigatran etexilate,…”
Get full text

Treatment patterns in children with autism in the United States by Monz, Brigitta U., Houghton, Richard, Law, Kiely, Loss, Georg

“…Children with autism receive different types of non‐drug treatments. We aimed to describe caregiver‐reported pattern of care and its variability by geography…”
Get full text

Sexual Problems and Distress in United States Women: Prevalence and Correlates by Shifren, Jan L., Monz, Brigitta U., Russo, Patricia A., Segreti, Anthony, Johannes, Catherine B.

“…To estimate the prevalence of self-reported sexual problems (any, desire, arousal, and orgasm), the prevalence of problems accompanied by personal distress,…”
Get full text

Major bleeding in patients with atrial fibrillation receiving vitamin K antagonists: a systematic review of randomized and observational studies by Roskell, Neil S, Samuel, Miny, Noack, Herbert, Monz, Brigitta U

“…Clinical trials have shown that anticoagulation with vitamin K antagonists (VKAs), e.g. warfarin, decreases the risk of stroke in patients with atrial…”
Get full text

Is the Comparator in Your Diagnostic Cost-Effectiveness Model “Standard of Care”? Recommendations from Literature Reviews and Expert Interviews on How to Identify and Operationalize It by Graziadio, Sara, Gregg, Emily, Allen, A. Joy, Neveux, Paul, Monz, Brigitta U., Davenport, Clare, Mealing, Stuart, Holmes, Hayden, Ferrante di Ruffano, Lavinia

“…This research aimed to develop best-practice recommendations for identifying the “standard of care” (SoC) and integrate it when it is the comparator in…”
Get full text

Evidence Synthesis and Linkage for Modelling the Cost-Effectiveness of Diagnostic Tests: Preliminary Good Practice Recommendations by Shinkins, Bethany, Allen, A. Joy, Karichu, James, Garrison, Louis P., Monz, Brigitta U.

“…Objectives To develop preliminary good practice recommendations for synthesising and linking evidence of treatment effectiveness when modelling the…”
Get full text

Measuring respiratory symptoms of COPD: performance of the EXACT- Respiratory Symptoms Tool (E-RS) in three clinical trials by Leidy, Nancy K, Murray, Lindsey T, Monz, Brigitta U, Nelsen, Linda, Goldman, Mitchell, Jones, Paul W, Dansie, Elizabeth J, Sethi, Sanjay

“…Symptomatic relief is an important treatment goal for patients with COPD. To date, no diary for evaluating respiratory symptoms in clinical trials has been…”
Get full text

Correlates of sexually related personal distress in women with low sexual desire by Rosen, Raymond C, Shifren, Jan L, Monz, Brigitta U, Odom, Dawn M, Russo, Patricia A, Johannes, Catherine B

“…Sexual distress is an important component of diagnostic criteria for sexual dysfunctions, but little is known about the factors associated with sexual distress…”
Get full text

Dabigatran versus rivaroxaban for the prevention of stroke and systemic embolism in atrial fibrillation in Canada. Comparative efficacy and cost-effectiveness by Kansal, Anuraag R, Sharma, Michael, Bradley-Kennedy, Carole, Clemens, Andreas, Monz, Brigitta U, Peng, Siyang, Roskell, Neil, Sorensen, Sonja V

“…Canadian patients with atrial fibrillation (AF) in whom anticoagulation is appropriate have two new choices for anticoagulation for prevention of stroke and…”
Get more information

Help-seeking behavior of women with self-reported distressing sexual problems by Shifren, Jan L, Johannes, Catherine B, Monz, Brigitta U, Russo, Patricia A, Bennett, Lee, Rosen, Ray

“…The objective was to describe the healthcare and information-seeking behavior of women with self-reported sexual problems and accompanying sexually related…”
Get more information

Distressing sexual problems in United States women revisited: prevalence after accounting for depression by Johannes, Catherine B, Clayton, Anita H, Odom, Dawn M, Rosen, Raymond C, Russo, Patricia A, Shifren, Jan L, Monz, Brigitta U

“…With data from the population-based Prevalence of Female Sexual Problems Associated with Distress and Determinants of Treatment Seeking (PRESIDE) study, which…”
Get full text

A Comparative Analysis of Models Used to Evaluate the Cost-Effectiveness of Dabigatran Versus Warfarin for the Prevention of Stroke in Atrial Fibrillation by Sorensen, Sonja V., Peng, Siyang, Monz, Brigitta U., Bradley-Kennedy, Carole, Kansal, Anuraag R.

“…Background A number of models exploring the cost-effectiveness of dabigatran versus warfarin for stroke prevention in atrial fibrillation have been published…”
Get full text

Responsiveness of the cough and sputum assessment questionnaire in exacerbations of COPD and chronic bronchitis by Monz, Brigitta U, Sachs, Paul, McDonald, Jeffrey, Crawford, Bruce, Nivens, Michael C, Tetzlaff, Kay

“…Summary Background To assess the responsiveness of the Cough and Sputum Assessment Questionnaire (CASA-Q) in COPD and chronic bronchitis patients recovering…”
Get full text

Proposing a standardized method for evaluating patient report of the intensity of dyspnea during exercise testing in COPD by Hareendran, Asha, Leidy, Nancy K, Monz, Brigitta U, Winnette, Randall, Becker, Karin, Mahler, Donald A

“…Measuring dyspnea intensity associated with exercise provides insights into dyspnea-limited exercise capacity, and has been used to evaluate treatment outcomes…”
Get full text

Quality of life outcomes among patients with depression after 6 months of starting treatment: Results from FINDER by Reed, Catherine, Monz, Brigitta U, Perahia, David G.S, Gandhi, Paul, Bauer, Michael, Dantchev, Nicolas, Demyttenaere, Koen, Garcia-Cebrian, Ana, Grassi, Luigi, Quail, Deborah, Tylee, Andre, Montejo, Angel L

“…Abstract Background Health-related quality of life (HRQoL) data in depression are limited. We studied the impact of antidepressant (AD) treatment on HRQoL…”
Get full text

Cost-effectiveness of tiotropium versus salmeterol: the POET-COPD trial by HOOGENDOORN, Martine, AL, Maiwenn J, BEEH, Kai-Michael, BOWLES, David, GRAF VON DER SCHULENBURG, J. Matthias, LUNGERSHAUSEN, Juliane, MONZ, Brigitta U, SCHMIDT, Hendrik, VOGELMEIER, Claus, RUTTEN-VAN MÖLKEN, Maureen P. M. H

“…The aim of this study was to perform a 1-yr trial-based cost-effectiveness analysis (CEA) of tiotropium versus salmeterol followed by a 5-yr model-based CEA…”
Get full text

Is the EQ-5D responsive to recovery from a moderate COPD exacerbation? by Goossens, Lucas M.A, Nivens, Michael C, Sachs, Paul, Monz, Brigitta U, Rutten-van Mölken, Maureen P.M.H

“…Summary Background To correctly estimate the cost-effectiveness of treatments that reduce COPD exacerbations, the utility gains from preventing exacerbations…”
Get full text